Head-to-head · Cost-Efficiency Index
NuBloom vs Pomegranate Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
NuBloom
Cost-first shoppers who want a physician-founded, whole-person GLP-1 program for women, in the 49 states it publishes as covered.
Visit NuBloomPomegranate Health
Cost-first shoppers who want a no-membership compounded GLP-1 whose semaglutide price is published on the product page itself.
Visit Pomegranate HealthThe verdict
NuBloom and Pomegranate Health tie on the Cost-Efficiency Index at 54/100, so neither wins outright on the numbers. For most shoppers we'd start with NuBloom (ranked #361, a hair above #362) — Cost-first shoppers who want a physician-founded, whole-person GLP-1 program for women, in the 49 states it publishes as covered. But Pomegranate Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs NuBloom.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | NuBloom | Pomegranate Health |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 54/100 |
| Semaglutide / mo | Not disclosed | $119/mo (starting price, compounded) |
| Tirzepatide / mo | $249/mo (microdose tier, compounded) | $149/mo (Starter tier, compounded) |
| Semaglutide / yr (modeled) | — | $1,428 |
| Tirzepatide / yr (modeled) | $2,988 | $1,788 |
| Coverage | 49 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #361 | #362 |
NuBloom
54/100Where the value is
- Transparent, openly published starting pricing: semaglutide $149/mo, tirzepatide $279/mo, with a cheaper $249/mo microdose tirzepatide option
- Founded and medically led by a named, identifiable physician (Dr. Marianne Pinkston Mueller)
- Full state-coverage list published and independently countable: 49 states, all except Mississippi
The tradeoffs
- Compounding pharmacy partner is never named anywhere on the site — only 'a state-licensed sterile compounding pharmacy partner'
- NuBloom's own independent LegitScript status isn't distinctly confirmed; the certification language attaches to its telehealth-platform partner, Telegra
Pomegranate Health
54/100Where the value is
- No membership and no consultation fee — the site states 'No Membership required' and 'Transparent pricing, no hidden fees'
- The semaglutide price sits in the product page's own static HTML, so it can be read before any intake
- Shipping is included: 'shipped discreetly to your door at no extra cost'
The tradeoffs
- The tirzepatide price is not on the public site at all — it exists only inside the in-app pricing portal, and there is no standalone tirzepatide product page to read it from
- Both published figures are floors, a 'Starts @' and a Starter tier, and no price is published for the dose you titrate up to
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.